Proposed New Indication
CPT-11 should be indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum
Recommended CPT-11/5-FU/LV regimens:
Saltz
de Gramont
Previous slide
Next slide
Back to first slide
View graphic version